← Evidence map

ReviewMolecular biology reports2022

CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.

Nianan Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35960410